Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Suciu

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Urology|June 1, 1984
Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762P H Smith, M Robinson, B Richards, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU GroupH J de Voogt, S Suciu, R Sylvester, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyJ H Mulder, P Dodion, F Cavalli, et al.
The Journal of Urology|April 1, 1989
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trialsH J de Voogt, S Suciu, R Sylvester, et al.
Bone Marrow Transplantation|December 1, 1989
Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative GroupR Willemze, R Zittoun, F Mandelli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The Children Leukemia Group: 30 years of research and achievementsJ Otten, N Philippe, S Suciu, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781)B M Henz, E Macher, E B Bröcker, et al.
Blut|January 1, 1988
Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML)H J Weh, R Kuse, R Hoffmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Locoregional recurrences after 649 modified radical mastectomies: incidence and significanceG Andry, S Suciu, P Vico, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Estrogen receptors and distribution of prognostic factors in primary breast cancerG Andry, W Mattheiem, S Suciu, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Urology|June 1, 1984
Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762P H Smith, M Robinson, B Richards, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU GroupH J de Voogt, S Suciu, R Sylvester, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyJ H Mulder, P Dodion, F Cavalli, et al.
The Journal of Urology|April 1, 1989
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trialsH J de Voogt, S Suciu, R Sylvester, et al.
Bone Marrow Transplantation|December 1, 1989
Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative GroupR Willemze, R Zittoun, F Mandelli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The Children Leukemia Group: 30 years of research and achievementsJ Otten, N Philippe, S Suciu, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781)B M Henz, E Macher, E B Bröcker, et al.
Blut|January 1, 1988
Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML)H J Weh, R Kuse, R Hoffmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Locoregional recurrences after 649 modified radical mastectomies: incidence and significanceG Andry, S Suciu, P Vico, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Estrogen receptors and distribution of prognostic factors in primary breast cancerG Andry, W Mattheiem, S Suciu, et al.
Pageof 15